145 related articles for article (PubMed ID: 12165034)
1. Seroreactivity to 19.5-kDa antigen in combination with absence of seroreactivity to 35-kDa antigen is associated with an increased risk of gastric adenocarcinoma.
Chua TS; Fock KM; Chan YH; Dhamodaran S; Sim CS; Ng TM; Teo EK
Helicobacter; 2002 Aug; 7(4):257-64. PubMed ID: 12165034
[TBL] [Abstract][Full Text] [Related]
2. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
[TBL] [Abstract][Full Text] [Related]
3. Seroreactivity to Helicobacter pylori antigens as a risk indicator of gastric cancer.
Karami N; Talebkhan Y; Saberi S; Esmaeili M; Oghalaie A; Abdirad A; Mostafavi E; Hosseini ME; Mohagheghi MA; Mohammadi M
Asian Pac J Cancer Prev; 2013; 14(3):1813-7. PubMed ID: 23679279
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa.
Lamarque D; Gilbert T; Roudot-Thoraval F; Deforges L; Chaumette MT; Delchier JC
Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):721-6. PubMed ID: 10445790
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Helicobacter pylori infection and intestinal metaplasia in subjects who had undergone surgery for gastric adenocarcinoma in Northwest Italy.
Palestro G; Pellicano R; Fronda GR; Valente G; De Giuli M; Soldati T; Pugliese A; Taraglio S; Garino M; Campra D; Cutufia MA; Margaria E; Spinzi G; Ferrara A; Marenco G; Rizzetto M; Ponzetto A
World J Gastroenterol; 2005 Dec; 11(45):7131-5. PubMed ID: 16437659
[TBL] [Abstract][Full Text] [Related]
6. Expression of tumor-associated Thomsen-Friedenreich antigen (T Ag) in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals.
Klaamas K; Kurtenkov O; Rittenhouse-Olson K; Brjalin V; Miljukhina L; Shljapnikova L; Engstrand L
Immunol Invest; 2002; 31(3-4):191-204. PubMed ID: 12472179
[TBL] [Abstract][Full Text] [Related]
7. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM
Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680
[TBL] [Abstract][Full Text] [Related]
8. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.
Palli D; Masala G; Del Giudice G; Plebani M; Basso D; Berti D; Numans ME; Ceroti M; Peeters PH; Bueno de Mesquita HB; Buchner FL; Clavel-Chapelon F; Boutron-Ruault MC; Krogh V; Saieva C; Vineis P; Panico S; Tumino R; Nyrén O; Simán H; Berglund G; Hallmans G; Sanchez MJ; Larrãnaga N; Barricarte A; Navarro C; Quiros JR; Key T; Allen N; Bingham S; Khaw KT; Boeing H; Weikert C; Linseisen J; Nagel G; Overvad K; Thomsen RW; Tjonneland A; Olsen A; Trichoupoulou A; Trichopoulos D; Arvaniti A; Pera G; Kaaks R; Jenab M; Ferrari P; Nesi G; Carneiro F; Riboli E; Gonzalez CA
Int J Cancer; 2007 Feb; 120(4):859-67. PubMed ID: 17131317
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of western blot CagA seropositivity in Helicobacter pylori-seropositive and -seronegative subjects.
Simán JH; Engstrand L; Berglund G; Florén CH; Forsgren A
Clin Diagn Lab Immunol; 2005 Feb; 12(2):304-9. PubMed ID: 15699426
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori antibodies and gastric cancer: a gender-related difference.
Janulaityte-Günther D; Kupcinskas L; Pavilonis A; Valuckas K; Percival Andersen L; Wadström T
FEMS Immunol Med Microbiol; 2005 May; 44(2):191-5. PubMed ID: 15866215
[TBL] [Abstract][Full Text] [Related]
11. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country.
Mitchell HM; Hazell SL; Li YY; Hu PJ
Am J Gastroenterol; 1996 Sep; 91(9):1785-8. PubMed ID: 8792699
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
[TBL] [Abstract][Full Text] [Related]
14. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma.
Rudi J; Kolb C; Maiwald M; Zuna I; von Herbay A; Galle PR; Stremmel W
Dig Dis Sci; 1997 Aug; 42(8):1652-9. PubMed ID: 9286230
[TBL] [Abstract][Full Text] [Related]
15. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
17. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.
Yamaoka Y; Kodama T; Kashima K; Graham DY
J Clin Pathol; 1999 Mar; 52(3):215-8. PubMed ID: 10450182
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori infection in gastric carcinoma.
Kato T; Saito Y; Niwa M; Inoue H; Motoyama N; Ogoshi K; Nashimoto A; Sasaki J; Sato T; Asaka M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S93-6. PubMed ID: 7735944
[TBL] [Abstract][Full Text] [Related]
19. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
[TBL] [Abstract][Full Text] [Related]
20. Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori.
Martín-de-Argila C; Boixeda D; Redondo C; Alvarez I; Gisbert JP; García Plaza A; Cantón R
Scand J Gastroenterol; 1997 Apr; 32(4):303-7. PubMed ID: 9140150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
